Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: A systematic analysis of published clinical trials

  • Karolin Bettge, Melanie Kahle, Mirna S. Abd El Aziz, Juris J. Meier, Michael A. Nauck
  • Diabetes Obesity and Metabolism, December 2016, Wiley
  • DOI: 10.1111/dom.12824

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Professor Michael A. Nauck